Evidence map›Paper›PMID 41656476›Full record

ArticleThe international journal of cardiovascular imaging2026

Non-invasive assessment of plaque characteristics in diffuse and focal coronary artery disease; plaque vulnerability and high-risk features.

Emine Sebnem Durmaz, Gunduz İncesu, Tolga Kaan Erden, Merdan Adiguzel, Sedef Mevlude Karabocek, Sedat Güney, Ayten Ozal, Ezgi Deniz Gokce, Selin İsmailoglu, Yusuf Eren Başer and 4 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Emine Sebnem DurmazCerrahpasa Medical Faculty, Radiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Gunduz İncesuCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Tolga Kaan ErdenCerrahpasa Medical Faculty, Radiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Merdan AdiguzelCerrahpasa Medical Faculty, Radiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Sedef Mevlude KarabocekCerrahpasa Medical Faculty, Radiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Sedat GüneyCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Ayten OzalCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Ezgi Deniz GokceCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Selin İsmailogluCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Yusuf Eren BaşerCerrahpasa Medical Faculty, Istanbul University - Cerrahpasa, Istanbul , Turkey.
Damla RaimoglouCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Murat CimciCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Bilgehan KaradagCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Eser DurmazCerrahpasa Medical Faculty, Cardiology department, Istanbul University - Cerrahpasa, Istanbul, Turkey. eser.durmaz@iuc.edu.tr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have suggested that focal and diffuse atherosclerotic coronary artery disease (CAD) have significantly different plaque composition, treatment efficacy and outcomes. In this study, we aimed to investigate the plaque characteristics of diffuse and focal lesions in patients who underwent coronary computed tomography angiography (CCTA) for the assessment of obstructive CAD. Patients with CAD-RADS score ≥ 2 were retrospectively reviewed. Plaque characteristics, composition and high-risk features were assessed. Plaques ≥ 20 mm or ≥ 25% of total vessel length were accepted as diffuse lesions and otherwise focal lesions. CCTA-derived plaque features and lesion-oriented cardiac outcomes were compared. After the exclusion of ineligible patients, 597 lesions of 441 patients were evaluated. The mean age of the study population was 55 ± 9,4 years. There were 463 focal lesions and 134 diffuse lesions. Diffuse lesions demonstrated higher calcification (p:0.001). CCTA-derived high-risk features, including spotty calcification (p:0.001), low-attenuation plaque (p: 0.041) and positive remodeling (p: 0.016), were more prevalent in focal disease. In addition, high-risk plaque was also higher in focal lesions(p: 0.022). Moreover, lesions with ≥ 70% plaque burden were significantly higher in focal lesions (p:0.044). Multivariate analysis demonstrated that plaque burden ≥ 70% and CCTA-derived high-risk plaque were independently associated with cardiac outcomes. During the follow-up, lesion-oriented myocardial infarction and revascularization were higher in diffuse disease (p < 0.001 and p:0.015, respectively). Diffuse and focal atherosclerotic lesions demonstrate significant differences regarding plaque vulnerability. Moreover, diffuse plaques have a worse prognosis compared to focal lesions.

Indexed as

Computed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseCoronary VesselsMultidetector Computed TomographyPlaque, AtheroscleroticVascular CalcificationAgedFemaleHumansMaleMiddle AgedMyocardial InfarctionPredictive Value of TestsPrognosisRetrospective StudiesCCTADiffuse diseaseFocal diseaseHigh-risk featuresVulnerability

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.